Search Results

Canadian Syncope Risk ScoreCanadian Syncope Risk Score

Predicts 30-day serious adverse events in patients presenting with syncope.Morbidity and mortality in syncope patients.

Rule Out

San Francisco Syncope RuleSan Francisco Syncope Rule

Predicts risk for serious outcomes at 7 days in patients presenting with syncope or near-syncope.Syncope risk stratification.

EGSYS (Evaluation of Guidelines in SYncope Study) Score for SyncopeEGSYS Score

Predicts likelihood that syncope is from cardiac cause.Identifies cardiac syncope.

OESIL Score for SyncopeOESIL Score

Estimates 12-month all-cause mortality in patients presenting with syncope.Mortality in syncope patients.

ROSE (Risk Stratification of Syncope in the Emergency Department) RuleROSE Rule

Predicts 1-month serious outcome or death in patients presenting with syncope.Morbidity and mortality in syncope patients.

Academic Research Consortium for High Bleeding Risk (ARC-HBR) CriteriaARC-HBR Criteria

Identifies patients undergoing percutaneous coronary intervention who are at high risk of major bleeding or intracranial hemorrhage.Bleeding risk classification post-PCI.

CAHP (Cardiac Arrest Hospital Prognosis) ScoreCAHP Score

Predicts poor prognosis after out-of-hospital cardiac arrest and guides utility of cardiac catheterization.Cardiac arrest prognosis.

Collection

Cardiac RiskCardiac Risk

Browse cardiac risk tools from primary to secondary prevention.Browse cardiac risk tools from primary to secondary prevention.

CHA₂DS₂-VA Score for Atrial Fibrillation Stroke RiskCHA₂DS₂-VA Score

Calculates stroke risk for patients with atrial fibrillation; similar to the CHA₂DS₂-VASc Score but without considering sex.Stroke risk in atrial fibrillation patients.

Formula

Corrected QT Interval (QTc)Corrected QT (QTc)

Corrects the QT interval for heart rate extremes (choose from Bazett, Fridericia, Framingham, Hodges, or Rautaharju formulas).Corrects QT interval.

Rule Out

Geneva Score (Revised) for Pulmonary EmbolismGeneva Score (Revised)

Objectifies risk of PE, like Wells' score.Risk of PE.

HFA-ICOS Baseline Cardio-Oncology Risk Assessment for Multiple Myeloma TherapiesHFA-ICOS Multiple Myeloma Therapies

Stratifies cardiotoxicity risk in cancer patients scheduled to receive multiple myeloma therapies.Multiple myeloma therapy cardiotoxicity risk assessment.

International Consensus Classification (ICC) Diagnostic Criteria for Systemic MastocytosisICC Diagnostic Criteria for Systemic Mastocytosis

Diagnoses systemic mastocytosis according to the International Consensus Classification (ICC).Systemic mastocytosis diagnostic criteria.

Katz Index of Independence in Activities of Daily Living (ADL)Katz Index of Independence in ADL

Assesses basic functional status to help quantify disability and care needs.Assesses functional status.

Mayo Alliance Prognostic System (MAPS) ScoreMAPS Score

Evaluates prognosis of systemic mastocytosis.Systemic mastocytosis prognosis.

Observatoire Régional Breton sur l’Infarctus (ORBI) Risk ScoreORBI Risk Score

Stratifies risk of in-hospital cardiogenic shock in patients undergoing primary percutaneous coronary intervention (PCI).Stratifies in-hospital cardiogenic shock risk after primary PCI.

Formula

Phenytoin (Dilantin) Correction for Albumin/Renal FailurePhenytoin (Dilantin) Correction

Corrects serum phenytoin level for renal failure and/or hypoalbuminemia.Corrected phenytoin level.

Pittsburgh Response to Endovascular therapy (PRE) ScorePRE Score

Identifies patients with anterior circulation large vessel occlusion (LVO) strokes likely to benefit from endovascular therapy.LVO stroke patients for endovascularization.

Pulmonary Artery Pulsatility Index (PAPi)PAPi

Assesses the risk of right ventricular dysfunction in patients with acute inferior wall myocardial infarction and after left ventricular assist device implantation.Assesses right ventricular dysfunction risk.

Scoring Mastocytosis (SCORMA) IndexSCORMA Index

Assesses severity of cutaneous mastocytosis in children and adults.Assesses severity of cutaneous mastocytosis.

Shanghai ScoreShanghai Score

Stratifies risk in suspected Brugada syndrome.Brugada syndrome risk.

Spanish Network on Mastocytosis (REMA) ScoreREMA Score

Predicts mast cell clonality on bone marrow biopsy in patients with systemic mast cell activation symptoms.Predicts mast cell clonality in symptomatic patients.

Sudbury Vertigo Risk ScoreSudbury Vertigo Risk Score

Identifies patients with vertigo who are at increased risk of a serious central diagnosis.Risk-stratify vertigo patients.